Novel chemistry for nucleic acid amplification

Atila BioSystems specializes in innovative nucleic acid amplification and detection technologies, focusing on providing rapid, accurate, and cost-effective molecular testing solutions. Their patented technologies, such as the 3N technology and Omega nucleic acid amplification, enhance sensitivity and specificity while eliminating common issues like primer dimer formation and non-specific amplification. These advancements allow for streamlined workflows, including extraction-free processes, which save time and resources in clinical and research settings. Atila's robust assay portfolio includes applications for cancer detection, blood screening, and various infectious diseases, demonstrating their commitment to improving diagnostic capabilities.

The company also offers the iAMP Personal Station Real-Time PCR System, which utilizes advanced fiber optic technology for precise temperature control and efficient sample processing. This system supports multiplex reactions, enabling simultaneous detection of multiple target sequences, thereby enhancing data collection and analysis. Atila BioSystems' technologies are designed to be user-friendly and adaptable for various applications, making them valuable tools for researchers and clinicians alike. With a focus on high performance and affordability, Atila BioSystems aims to make molecular testing accessible and effective for a wide range of healthcare needs.

United States

Focusing on developing the best nucleic acid amplification and detection technologies for clinical molecular diagnostics - COVID-19 (FDA EUA Approved), Non Invasive Prenatal Test, HPV Detection, STI, NGS Cancer Panel (Lung, Breast, Colorectal), and many more.

Atila BioSystems

Company Details